Cite
MLA Citation
Bernard Tawfik et al.. “Costs of treatment change following first-line somatostatin analog monotherapy among patients with neuroendocrine tumors.” Journal of medical economics, vol. 24, 2021, pp. 1337–1345. http://access.bl.uk/ark:/81055/vdc_100146314786.0x00002a